AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Tequin label changes address dysglycemia.(Clinical Rounds)
Bristol-Myers Squibb Co. has announced labeling changes for Tequin (gatifloxacin) that update the prescription information as a result of continued reports of cases of hypoglycemia and hyperglycemia in patients taking the drug.
Tequin is indicated for the treatment of patients with pneumonia, bronchitis, uncomplicated gonorrhea, and various infections including infections of the urinary tract, kidneys, and skin.
The prescribing information has been revised to include a contraindication in diabetic patients. In addition, the warnings and precautions sections have been updated to identify other risk factors for dysglycemia while taking the drug and to include a recommendation for close medical monitoring.
In particular, coadministration of glucose altering medications, older age, and renal insufficiency have been identified as other risk factors. Physicians considering prescribing or dispensing Tequin are encouraged to discuss how patients who may be at risk for hypoglycemia and/or ...
- Label changes address dysglycemia.(News)(Brief article)
- Magazine article from: Family Practice News Wachter, Kerri March 15, 2006 700+ words
...Bristol-Myers Squibb Co. has announced labeling changes for Tequin (gatifloxacin) that update the prescription information as...hypoglycemia and hyperglycemia in patients taking the drug. Tequin is indicated for the treatment of patients with pneumonia...
- Tequin Gets FDA Approval For Short Course Treatment.
- Newspaper article from: TB & Outbreaks Week December 11, 2001 700+ words
...Squibb Co. (BMY) has announced that Tequin (gatifloxacin), a broad-spectrum...exacerbation of chronic bronchitis (ABECB). Tequin is already approved for ABECB, acute...very impressed that, in our research, Tequin has been shown to be effective in treating...
- Bristol-Myers Squibb's Quinolone Antibiotic TEQUIN(TM) (gatifloxacin) Passes...
- Press release article from: PR Newswire August 1, 2000 700+ words
TEQUIN Sets New Quinolone Six-Month Prescription...Squibb Company (NYSE: BMY) announced that TEQUIN, a quinolone antibiotic, has been prescribed...Drug Administration on December 17, 1999. TEQUIN is the first quinolone antibiotic to achieve...
- Bristol-Myers Squibb Receives FDA Approval for TEQUIN(R) For the Short Course...
- Press release article from: PR Newswire November 7, 2001 700+ words
...Company (NYSE: BMY) has announced that TEQUIN(R) (gatifloxacin), a broad-spectrum...exacerbation of chronic bronchitis (ABECB). TEQUIN(R) is already approved for ABECB...very impressed that, in our research, TEQUIN(R) has been shown to be effective in...
- Bristol-Myers Squibb Receives FDA Approval for TEQUIN(TM), A New Type of...
- Press release article from: PR Newswire January 18, 2000 700+ words
...Company (NYSE: BMY) has announced that TEQUIN(TM) (gatifloxacin), a new type of...respiratory tract infections (RTIs). TEQUIN was designed with a unique 8-methoxy...resistance of gram-positive bacteria. TEQUIN is the first and only antibiotic of this...
- One Million New U.S. Prescriptions Reached by TEQUIN(R) (gatifloxacin),...
- Press release article from: PR Newswire November 28, 2000 700+ words
TEQUIN Continues to Outpace First-Year New Rxs...Squibb Company (NYSE: BMY) announced that TEQUIN, a quinolone antibiotic, reached the one...Drug Administration on December 17, 1999, TEQUIN is the only quinolone antibiotic to achieve...
- Largest Clinical Study Confirms the Safety and Efficacy of TEQUIN(R)...
- News wire article from: Canadian Corporate News September 20, 2000 700+ words
...TORONTO, Sep 20, 2000 The results of the TEQUIN(R) (gatifloxacin) Clinical Experience...15, 000 patients who were treated with TEQUIN the quinolone antibiotic marketed by Bristol...to validate the efficacy and safety of TEQUIN in the community setting. "We are pleased...
- Hagens Berman Sobol Shapiro: Suit Filed Against Bristol-Myers Squibb Over...
- Press release article from: PR Newswire July 31, 2007 700+ words
...Corporation , claiming its antibiotic drug Tequin causes severe blood-sugar issues in...issues including diabetes, and death. Tequin and its generic equivalent gatifloxacin...from HBSS, safety concerns regarding Tequin began to surface in 2001, two years after...